# üìä Pharmaceutical Sales Analytics Dashboard
## Comprehensive Business Intelligence Report

> **Executive Summary**: This analysis transforms 3+ million sales transactions into actionable insights, revealing revenue patterns, operational opportunities, and strategic recommendations for pharmaceutical retail operations.

---

## üìã Table of Contents

1. [Executive Summary](#executive-summary)
2. [The Story Behind the Numbers](#the-story-behind-the-numbers)
3. [Key Business Questions Answered](#key-business-questions-answered)
4. [Performance Metrics](#performance-metrics)
5. [Visual Analytics](#visual-analytics)

---

## üéØ Executive Summary

### The Big Picture
Over **10 months** (January - October 2025), our pharmaceutical retail network generated **$119.4 million** in total sales across **3+ million transactions**. This analysis uncovers critical insights about when customers shop, which products drive revenue, which stores outperform, and how discounts impact profitability.

### Top 3 Insights
1. **Peak Performance Window**: Evening hours (7 PM - 11 PM) generate 30%+ of daily revenue
2. **Store Dominance**: Store P155 alone accounts for 13.8% of total network revenue
3. **Product Velocity**: Specialty medications like Imbruvica move at $55K+ per active day

---

## üìñ The Story Behind the Numbers

### Chapter 1: The Revenue Journey

Our sales journey begins in January 2025 with $11.1M and shows a steady upward trajectory, peaking in July at $13.0M‚Äîa **17% increase** from the starting point. However, the story isn't linear. June experienced a dip to $11.2M, creating a "valley" before the July peak, suggesting potential operational challenges or seasonal factors that require investigation.

**The Plot Twist**: October shows a decline to $11.6M, ending the period 4.4% below the peak. This pattern suggests we may need to investigate:
- Seasonal demand fluctuations
- Inventory management during peak months
- Marketing campaign effectiveness

![Monthly Revenue Trend](screenshots/monthly_revenue_trend.png)
*Figure 1: Monthly revenue shows growth trajectory with July peak and October decline*

---

### Chapter 2: The Store Champions

Store P155 emerges as the undisputed champion, generating **$16.4 million**‚Äîmore than double the second-place store (P227 at $7.4M). This represents **13.8% of total network revenue** from a single location.

**The Question**: Why does P155 outperform so dramatically?
- Location advantage (high-traffic area, accessibility)
- Superior inventory management
- Exceptional staff performance
- Marketing effectiveness
- Customer loyalty programs

**The Opportunity**: If we can replicate P155's success factors across other stores, even a 20% improvement in underperforming stores could add millions in revenue.

![Store Revenue Comparison](screenshots/store_revenue_bar.png)
*Figure 2: Store P155 dominates with $16.4M, more than double the next best performer*

---

### Chapter 3: The Product Portfolio Story

Our product portfolio tells a story of specialization and high-value transactions. The top 10 products alone generate **$10.0 million** (8.4% of total revenue), with diabetes management products leading the charge:

1. **Novorapid Flexpen** - $1.26M (diabetes management)
2. **Free Style Libre-2** - $1.13M (diabetes monitoring)
3. **Gloclav 1Gm** - $1.06M (antibiotic)

**The Insight**: Chronic disease management products (diabetes, cardiovascular) dominate our top performers, indicating:
- Strong customer retention
- Recurring revenue streams
- High customer lifetime value

![Top Products Revenue](screenshots/top_10_products.png)
*Figure 3: Top 10 products generate $10M, led by diabetes management solutions*

---

### Chapter 4: The Time-Based Patterns

#### The Daily Rhythm
Our customers have a clear shopping rhythm. Sales activity builds throughout the day, with **evening hours (7 PM - 11 PM) generating the highest revenue**:
- **9 PM**: $9.7M (peak hour)
- **10 PM**: $9.4M
- **11 PM**: $9.1M

**The Business Implication**: 
- Staffing should be optimized for evening shifts
- Promotional campaigns should target evening hours
- Inventory restocking should occur before 7 PM

#### The Weekly Pattern
Sunday emerges as the strongest sales day ($18.3M), while Friday is the weakest ($13.6M)‚Äîa **35% difference**. This pattern suggests:
- Weekend shopping behavior (Sunday preparation for the week)
- Friday may be impacted by weekend planning or reduced foot traffic
- Opportunity to boost Friday sales through targeted promotions

![Revenue Heatmap](screenshots/revenue_heatmap_day_hour.png)
*Figure 4: Heatmap reveals evening hours and Sunday as peak sales periods*

---

### Chapter 5: The Discount Strategy

Our discount analysis reveals a fascinating story. The "Unknown" discount type shows a **4.83x ROI**‚Äîthe highest of all discount categories. This suggests either:
1. A highly effective discount program that needs proper categorization
2. Data quality issues requiring investigation
3. A hidden discount strategy that's working exceptionally well

**Discount ROI Breakdown**:
- Unknown: 4.83x ROI ($118M sales from $24.4M discounts)
- Bbuy: 2.01x ROI
- Percentage (%): 1.85x ROI
- P: 1.20x ROI

**The Recommendation**: Investigate the "Unknown" category‚Äîif it represents a specific strategy, we should formalize and scale it. If it's a data issue, we need proper categorization to make informed discount decisions.

---

### Chapter 6: Product Velocity - The Fast Movers

Product velocity (sales per active day) reveals which products need frequent restocking and which generate rapid revenue:

**Top Velocity Products**:
1. **Imbruvica 140Mg** - $55,749.60 per active day
2. **Tagrisso 80Mg** - $32,955.48 per active day
3. **Skyrizi 360 Mg** - $23,183.58 per active day

**The Operational Impact**:
- These high-velocity products require tight inventory management
- Stockouts could result in significant lost revenue
- Consider automated reordering systems for these items

---

### Chapter 7: The People Behind the Sales

Our 130 pharmacists drive the customer experience. The analysis reveals:
- Individual performance variations across the network
- Monthly trends showing growth or decline patterns
- Store-specific pharmacist effectiveness

**Key Findings**:
- Some pharmacists show consistent growth across months
- Others show declining trends requiring support or training
- Store-pharmacist combinations reveal performance synergies

![Pharmacist Performance](screenshots/pharmacist_performance.png)
*Figure 5: Individual pharmacist performance trends reveal growth opportunities*

---

## ‚ùì Key Business Questions Answered

### Q1: "What's our total revenue and how is it trending?"
**Answer**: $119.4M over 10 months, with a peak in July ($13.0M) and a decline in October ($11.6M). Overall growth trajectory is positive, but October decline needs investigation.

![Monthly Revenue](screenshots/monthly_revenue_trend.png)

---

### Q2: "Which stores are performing best and worst?"
**Answer**: 
- **Best**: P155 ($16.4M - 13.8% of total revenue)
- **Top 3**: P155, P227 ($7.4M), P031 ($6.8M)
- **Opportunity**: Significant performance gap suggests replication potential

![Store Performance](screenshots/store_revenue_bar.png)

---

### Q3: "What are our best-selling products?"
**Answer**: Top 10 products generate $10M (8.4% of revenue):
1. Novorapid Flexpen ($1.26M)
2. Free Style Libre-2 ($1.13M)
3. Gloclav 1Gm ($1.06M)

Chronic disease management products dominate, indicating strong recurring revenue.

![Top Products](screenshots/top_10_products.png)

---

### Q4: "When do customers shop most?"
**Answer**: 
- **Peak Hours**: 7 PM - 11 PM (evening rush)
- **Peak Day**: Sunday ($18.3M)
- **Weakest Day**: Friday ($13.6M)

Staffing and promotions should align with these patterns.

![Time Patterns](screenshots/revenue_heatmap_day_hour.png)

---

### Q5: "Are our discounts working? What's the ROI?"
**Answer**: Discount ROI varies significantly:
- Unknown: 4.83x (highest, needs investigation)
- Bbuy: 2.01x
- Percentage: 1.85x
- P: 1.20x (lowest)

The "Unknown" category requires immediate attention‚Äîeither it's a highly effective strategy to scale, or a data quality issue to fix.

---

### Q6: "Which products need frequent restocking?"
**Answer**: High-velocity products (sales per active day):
- Imbruvica: $55,749/day
- Tagrisso: $32,955/day
- Skyrizi: $23,183/day

These require tight inventory management and automated reordering.

---

### Q7: "How are our pharmacists performing?"
**Answer**: Performance varies significantly. Some show consistent growth, others show declining trends. Individual monthly trends reveal:
- Top performers with sustained growth
- Pharmacists needing support or training
- Store-pharmacist performance synergies

![Pharmacist Trends](screenshots/pharmacist_monthly_trends.png)

---

### Q8: "What's the price distribution across product categories?"
**Answer**: Item classes ZMDN and ZCOS show wide price variability (high-value specialty medications), while others remain consistently low. This suggests distinct pricing strategies across categories.

![Price Distribution](screenshots/price_distribution_boxplot.png)

---

### Q9: "How do discounts impact total sales?"
**Answer**: Small discounts dominate the transaction volume, but occasional large discounts can drive high sales. This suggests selective, strategic discounting may be more effective than blanket promotions.

![Discount Impact](screenshots/discount_scatter.png)

---

### Q10: "What's the revenue contribution by product category?"
**Answer**: [Pie chart shows distribution] - Understanding category contribution helps with:
- Inventory allocation
- Marketing budget distribution
- Strategic focus areas

![Category Revenue](screenshots/category_pie_chart.png)

---

### Q11: "How do stores perform month-over-month?"
**Answer**: Store growth trends vary significantly. Some stores show consistent growth, others show volatility. Faceted analysis reveals:
- Stores with steady upward trends
- Stores with declining performance
- Seasonal patterns by location

![Store Growth Trends](screenshots/store_growth_trends.png)

---

### Q12: "What's our average transaction value?"
**Answer**: Calculated from total sales and transaction count. This metric helps understand:
- Customer spending behavior
- Upselling opportunities
- Pricing strategy effectiveness

---

## üìà Performance Metrics

### Revenue Metrics
| Metric | Value |
|--------|-------|
| **Total Sales** | $119,396,553.31 |
| **Average Monthly Sales** | $11,939,655.33 |
| **Peak Month** | July 2025 ($13,029,154.77) |
| **Lowest Month** | February 2025 ($10,807,655.17) |
| **Growth Rate** | +17% (Jan to Peak) |

### Top Performers
| Category | Top Performer | Value |
|----------|---------------|-------|
| **Store** | P155 | $16,431,968.52 |
| **Product** | Novorapid Flexpen | $1,260,409.14 |
| **Hour** | 9 PM | $9,699,668.46 |
| **Day** | Sunday | $18,285,106.24 |

### Operational Metrics
- **Total Transactions**: 3,092,855
- **Active Pharmacists**: 130
- **Product Velocity Leader**: Imbruvica ($55,749.60/day)
- **Discount ROI Leader**: Unknown category (4.83x)

---

## üìä Visual Analytics

### 1. Monthly Revenue Trend
Shows the growth trajectory with July peak and October decline.
![Monthly Revenue](screenshots/monthly_revenue_trend.png)

### 2. Store Performance Comparison
Reveals P155's dominance and identifies underperforming stores.
![Store Revenue](screenshots/store_revenue_bar.png)

### 3. Top Products Analysis
Highlights best-selling products and revenue concentration.
![Top Products](screenshots/top_10_products.png)

### 4. Price Distribution by Category
Shows pricing strategies and product category diversity.
![Price Distribution](screenshots/price_distribution_boxplot.png)

### 5. Discount Impact Analysis
Reveals relationship between discounts and sales volume.
![Discount Impact](screenshots/discount_scatter.png)

### 6. Revenue Heatmap (Day √ó Hour)
Identifies peak sales periods for operational optimization.
![Revenue Heatmap](screenshots/revenue_heatmap_day_hour.png)

### 7. Category Revenue Contribution
Shows revenue distribution across product categories.
![Category Revenue](screenshots/category_pie_chart.png)

### 8. Store Growth Trends
Faceted view of month-over-month performance by store.
![Store Growth](screenshots/store_growth_trends.png)

### 9. Pharmacist Performance
Individual performance trends and top performers.
![Pharmacist Performance](screenshots/pharmacist_performance.png)

